FMO5 and Anxiety: The present study demonstrates that chronic daily treatment with 30 mg/kg/day Apocynin normalises hyperlocomotion and anxiety response, improves learning and normalises free radical production, reducing intracellular NADPH oxidase signalling and also the normalisation of the oxidation of lipids and proteins in the Fmr1-KO mouse.